D. Tsavdaridis

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides et al. · Journal of Clinical Oncology · 2002 · 255 citations

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Dimosthenis Skarlos, E. Samantas, Evangelos Briassoulis et al. · Annals of Oncology · 2001 · 125 citations · Full text

Radiation Medicine, Health Sciences, Radiation Therapy +10

Continuation of Trastuzumab Beyond Disease Progression Is Feasible and Safe in Patients with Metastatic Breast Cancer: A Retrospective Analysis of 80 Cases by the Hellenic Cooperative Oncology Group

George Fountzilas, Evangelia Razis, D. Tsavdaridis et al. · Clinical Breast Cancer · 2003 · 105 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +7

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Dimosthenis Skarlos, Urania Dafni et al. · Annals of Oncology · 2005 · 99 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +5

Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer

George Fountzilas, D. Tsavdaridis, Anna Kalogera‐Fountzila et al. · Annals of Oncology · 2001 · 75 citations · Full text

Advanced Breast Cancer, Breast Oncology, Medicine +7